In vivo multiphoton-microscopy of picosecond-laser-induced optical breakdown in human skin.
Improvements in skin appearance resulting from treatment with fractionated picosecond-lasers have been noted, but optimizing the treatment efficacy depends on a thorough understanding of the specific skin response. The development of non-invasive laser imaging techniques in conjunction with laser therapy can potentially provide feedback for guidance and optimizing clinical outcome.



The purpose of this study was to demonstrate the capability of multiphoton microscopy (MPM), a high-resolution, label-free imaging technique, to characterize in vivo the skin response to a fractionated non-ablative picosecond-laser treatment.



Two areas on the arm of a volunteer were treated with a fractionated picosecond laser at the Dermatology Clinic, UC Irvine. The skin response to treatment was imaged in vivo with a clinical MPM-based tomograph at 3 hours and 24 hours after treatment and seven additional time points over a 4-week period.



MPM revealed micro-injuries present in the epidermis. Pigmented cells were particularly damaged in the process, suggesting that melanin is likely the main absorber for laser induced optical breakdown.



Damaged individual cells were distinguished as early as 3 hours post pico-laser treatment with the 532 nm wavelength, and 24 hours post-treatment with both 532 and 1064 nm wavelengths. At later time points, clusters of cellular necrotic debris were imaged across the treated epidermis. After 24 hours of treatment, inflammatory cells were imaged in the proximity of epidermal micro-injuries. The epidermal injuries were exfoliated over a 4-week period.



This observational and descriptive pilot study demonstrates that in vivo MPM imaging can be used non-invasively to provide label-free contrast for describing changes in human skin following a fractionated non-ablative laser treatment. The results presented in this study represent the groundwork for future longitudinal investigations on an expanded number of subjects to understand the response to treatment in different skin types with different laser parameters, critical factors in optimizing treatment outcome. Lasers Surg. Med. 49:555-562, 2017. © 2017 Wiley Periodicals, Inc.
Beckman Laser Institute, Laser Microbeam and Medical Program, University of California Irvine, Irvine, California, 92612.
Mihaela
M
Balu
Beckman Laser Institute, Laser Microbeam and Medical Program, University of California Irvine, Irvine, California, 92612.
Griffin
G
Lentsch
Department of Dermatology, University of California, Irvine, California, 92697.
Dorota Z
DZ
Korta
JenLab GmbH, Schillerstrasse 1, Jena, Germany.|Department of Biophotonics and Laser Technology, Saarland University, Saarbrücken, Germany.
Karsten
K
König
Department of Dermatology, University of California, Irvine, California, 92697.
Kristen M
KM
Kelly
Beckman Laser Institute, Laser Microbeam and Medical Program, University of California Irvine, Irvine, California, 92612.
Bruce J
BJ
Tromberg
Department of Dermatology, University of California, Irvine, California, 92697.
Christopher B
CB
Zachary
D004817:Epidermis / Q000000981:diagnostic imaging / Q000528:radiation effects*; D064368:Healthy Volunteers; D006801:Humans; D053844:Lasers, Solid-State; D036641:Microscopy, Fluorescence, Multiphoton; D010865:Pilot Projects
in vivo imaging; laser induced optical breakdown; noninvasive multiphoton microscopy